Follow us on :


Cancer Reports and Reviews

Online ISSN: 2513-9290

Dung-Fang Lee (Editor-in-Chief)

 The University of Texas

Cancer Reports and Reviews is a bimonthly, peer-reviewed journal provides cancer care professionals with up-to-date information on all aspects of cancer diagnosis, treatment, and prevention.

CRR will feature original research, review papers, clinical studies, editorials, expert opinion and perspective papers, commentaries, and book reviews.

CRR welcomes direct submissions from authors: Attach your word file with e-mail and send it to submissions@oatext.com alternatively to editor.crr@oatext.com

Please, follow the Instructions for Authors. In the cover letter add the name and e-mail address of 5 proposed reviewers (we can choose them or not).

Copyright is retained by the authors and articles can be freely used and distributed by others. Articles are distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published by CRR, is properly cited.

Dung-Fang Lee


Dr. Lee received his Bachelor degree in Chemical Engineering and Master degree in Radiation Biology from National Tsing Hua University in Taiwan and PhD degree in Cancer Biology from the University Of Texas Graduate School Of Biomedical Sciences at Houston. In 2016 after completing the post-doctoral training in the Black Family Stem Cell Institute at Icahn School of Medicine at Mount Sinai, Dr. Lee joined the Department of Integrative Biology and Pharmacology, and the Center for Stem Cell and Regenerative Medicine at the University of Texas Health Science Center at Houston as an Assistant Professor. Dr. Lee is the first person applying iPSC disease model to study familial cancer syndrome. Currently, Dr. Lee is the CPRIT scholar in Cancer Research.

The Lee laboratory is dedicated to understand cancer pathological mechanisms by using patient-specific iPSCs and/or engineered ESCs. The Lee laboratory has established the first human Li-Fraumeni syndrome (LFS) disease model by using LFS patient-specific iPSCs to delineate the pathological mechanisms caused by mutant p53 in osteosarcoma. The Lee laboratory continues to apply TALENs and CRISPR/Cas9 genome editing tools to create variant p53 mutations in pluripotent stem cells (PSCs; e.g., iPSCs and ESCs) in order to explore the role of mutant p53 in osteosarcomagenesis. The Lee laboratory also works on modeling familial cancer syndromes with osteosarcoma predisposition by PSCs. Currently, the Lee laboratory applies whole genome sequencing, screening approaches and systems-level analyses to explore early genomic alterations and to understand dynamic alterations of the genomic landscape of LFS-associated osteosarcoma.

Dr. Lee’s research has been well recognized and published in journals as Cell, Cell Stem Cell, Molecular Cell, Cancer Cell, Cell Reports, Nature, Nature Cell Biology, Nature Protocols, Journal of Clinical Investigation, Trends in Cancer, and Trends in Biochemical Sciences.

Editorial Board


Dayson Friaca Moreira

Beckman Research Institute
USA

Shouhao Zhou

Department of Biostatistics
Division of Quantitative Sciences
The University of Texas
USA

Dr. Alireza Heidari

Faculty of Chemistry
California South University
Irvine, California
USA


Vladimir Zaichick

Principal Investigator
Medical Radiological Research Centre
RUSSIA

Ritesh Kumar

Assistant Professor
Radiation Oncology AIIMS, New Delhi
India

Sachin C. Sarode

Department of Oral Pathology and Microbiology
Dr. D.Y. Patil Dental College
India


Rajkumar K

Professor & Head Of the Department
SRM University
India

Chao-Kai Chou

Assistant Professor
Department of Molecular Oncology
UT MD Anderson Cancer Center
USA

Francesca Aguilo

Assistant Professor. Wallenberg Centre for Molecular Medicine,
Department of Medical Biosciences, Umeå University,
Sweden


Jian Chen

Assistant Professor
Department of Gastroenterology
Division of Internal Medicine
The University of Texas MD Anderson Cancer Center
Houston, Texas, USA

Xin Zhang

Principle Investigator
High Magnetic Field Laboratory
Chinese Academy of Sciences
China

Filipe Pereira

Group leader
Cell Reprograming and Developmental Hematopoiesis Laboratory
Center for Neuroscience and Cell Biology (CNC)
Universidade de Coimbra
Portugal


Chia-Hsin (Lori) Chan

Assistant Professor
Department of Pharmacological Sciences
Stony Brook University
New York, USA

Zhao Ruiying

Assistant Professor
Department of Integrative Biology & Pharmacology
University of Texas McGovern Medical School
USA

Junjun Ding

Professor
Zhongshan School of Medicine
Sun Yat-sen University
P.R. China


Jer-Yen Yang

Department of Basic Medical Sciences
Center for Cancer Research
Purdue University College of Veterinary Medicine
Indiana

Adrian Pablo Hunis

Board Certified in Medical Oncology
Assistant Professor of Internal Medicine
School of Medicine, University of Buenos Aires, Argentina Director, Carer Specialist in Oncology, School of Medicine
University of Buenos Aires (UBA), Argentina
Head Professor of Oncology, Maimonides University, Argentina

In Press

Volume 1, Issue 5


De-programming colorectal cancer by increase in cholesterol level

Robert Skopec

Review Article-Cancer Reports and Reviews (CRR)

July 17, 2017


Intraductal papillary neoplasm of the bile duct found incidentally during examination of colonic disease: A case report

Katsuhiro Tomofuji Yoshihiro Mise Hiromichi Ito Takeaki Ishizawa Yosuke Inoue Yu Takahashi Akio Saiura

Case Report-Cancer Reports and Reviews (CRR)

July 19, 2017


Investigation of genomic instability in cholesteatoma of patients

Zeynep Betul SARI Kayhan OZTURK Hasan ACAR

Research Article-Cancer Reports and Reviews (CRR)

July 31, 2017


Current Issue

Volume 1, Issue 4


Cancer liquid biopsy - A real advance of science

Adrian Pablo Hunis

Editorial-Cancer Reports and Reviews (CRR)

May 14, 2017


Prognostic factors in the management of osteosarcoma

Oboirien M Agbo SP Ajiboye LO Galadima BA Nwashili RC

Research Article-Cancer Reports and Reviews (CRR)

May 15, 2017


Rhabdomyosarcoma mimicking Acute Leukemia in a 42-year-old female

Rakul Nambiar K Anoop TM Prakash NP

Case Report-Cancer Reports and Reviews (CRR)

May 17, 2017


Complete prevention and rapid sustained elimination of chemoradiation toxic mucositis, a case series with implications for mucositis pathobiology, cost of care, morbidity and premature cancer deaths

Ricky W. McCullough

Research Article-Cancer Reports and Reviews (CRR)

May 26, 2017


Use of molecular docking in the search for new anti-angiogenic agents

Hanane Boucherit Nousseiba Zouaghi Ziani Sara Abdelouahab Chikhi Abderrahmane Bensegueni Amina Merzoug

Research Article-Cancer Reports and Reviews (CRR)

May 31, 2017


Spinal cord involvement in a Burkitt lymphoma patient

Aude Quentin-Gondard Marielle Legoff Myriam Edjlali Guillaume Geri Barbara Burroni Benedicte Deau Lise Willems Dominique Magli-Barioz Farhad Heshmati Frédéric Pène David Calvet Didier Bouscary Jerome Tamburini

Case Report-Cancer Reports and Reviews (CRR)

June 20, 2017


Archive


Volume 1

Cancer liquid biopsy - A real advance of science

Adrian Pablo Hunis

Editorial-Cancer Reports and Reviews (CRR)

May 14, 2017


Prognostic factors in the management of osteosarcoma

Oboirien M Agbo SP Ajiboye LO Galadima BA Nwashili RC

Research Article-Cancer Reports and Reviews (CRR)

May 15, 2017


Rhabdomyosarcoma mimicking Acute Leukemia in a 42-year-old female

Rakul Nambiar K Anoop TM Prakash NP

Case Report-Cancer Reports and Reviews (CRR)

May 17, 2017


Complete prevention and rapid sustained elimination of chemoradiation toxic mucositis, a case series with implications for mucositis pathobiology, cost of care, morbidity and premature cancer deaths

Ricky W. McCullough

Research Article-Cancer Reports and Reviews (CRR)

May 26, 2017


Use of molecular docking in the search for new anti-angiogenic agents

Hanane Boucherit Nousseiba Zouaghi Ziani Sara Abdelouahab Chikhi Abderrahmane Bensegueni Amina Merzoug

Research Article-Cancer Reports and Reviews (CRR)

May 31, 2017


Spinal cord involvement in a Burkitt lymphoma patient

Aude Quentin-Gondard Marielle Legoff Myriam Edjlali Guillaume Geri Barbara Burroni Benedicte Deau Lise Willems Dominique Magli-Barioz Farhad Heshmati Frédéric Pène David Calvet Didier Bouscary Jerome Tamburini

Case Report-Cancer Reports and Reviews (CRR)

June 20, 2017


Randomized clinical study of SCP pacliataxel in patients with advanced cervical cancer

Timothy Allen Nepton Sheik Khoni Bruce Dunphy Naveed Basha Court

Research Article-Cancer Reports and Reviews (CRR)

February 18, 2017


Extremely high serum level of carbohydrate antigen 19-9 in a patient with colon adenocarcinoma

Jing Deng Qi Shi Wasique Mirza Mladen Jecmenica Michael Yoder Rajan Mulloth Erin Gordon Arpit Sothwal Sowmya Thanneeru Sirish Dharmapuri

Research Article-Cancer Reports and Reviews (CRR)

March 10, 2017


A rare case of humoral hypercalcemia of malignancy resulting from urothelial carcinoma

Jonathan Slusser Brian Beluch Alan J Shienbaum

Case Report-Cancer Reports and Reviews (CRR)

March 25, 2017


Physical exercises programs for cancer patients: what else’s new?

Francesca Rodà Federica Petraglia Veronica Scaltriti Cosimo Costantino Vittorio Franciosi Fabio Pessina Rodolfo Brianti

Commentary Article-Cancer Reports and Reviews (CRR)

May 04, 2017


Palliative sedation and oncological active treatment at the end of life; Is there any difference between the hospital and at home?

Carmen Herrero-Vicent Sara García-Agudo Alejandro González-Álvarez Salvador Martín-Utrillas Sergio Sandiego Vicente Guillem-Porta

Research Article-Cancer Reports and Reviews (CRR)

May 06, 2017


A lady with excertional dyspnoea due to cardiac metastases

Rakul Nambiar K Anoop TM Prakash NP

Case Report-Cancer Reports and Reviews (CRR)

May 12, 2017


Social support, quality of life and mental health status in breast cancer patients

Jenesh Singh Shrestha Alish Shrestha Abja Sapkota Rakshya Sharma Samip Shrestha Sudip Shestha Kapendra Sekhar Amayta Madhav Gautam

Research Article-Clinical Research and Trials (CRT)

February 01, 2017


Immunotherapy and small cell lung cancer (SCLC)

Timothy Allen Nepton Sheikh-Khoni Naveed Basha Court

Research Article-Cancer Reports and Reviews (CRR)

February 04, 2017


Immunotherapy and squamous cell carcinoma

Timothy Allen Nepton Sheikh-Khoni Naveed Basha Court

Research Article-Cancer Reports and Reviews (CRR)

February 04, 2017


Immunotherapy and urinary bladder cancer

Timothy Allen Nepton Sheikh-Khoni Naveed Basha Court

Short Communication-Cancer Reports and Reviews (CRR)

February 07, 2017


The histogenesis of Ewing Sarcoma

Jian Tu Zijun Huo Julian Gingold Ruiying Zhao Jingnan Shen Dung-Fang Lee

Short Communication-Cancer Reports and Reviews (CRR)

February 07, 2017


Propolis gel versus benzydamine in preventing oral mucositis for patients irradiated in head and neck: a preliminary study

Noronha VRAS Abdo EN Persio FPCL SantosVR

Research Article-Cancer Reports and Reviews (CRR)

February 17, 2017


Hypoxia induces therapeutic resistance and enhances subsequent reformulated tumorigenesis and metastasis

Lawrence M. Agius

Case Report-Cancer Reports and Reviews (CRR)

December 23, 2016


A rare case of subungual exostosis of the hallux in an adolescent-a clinico-pathological review of literature

Supreeth Nekkanti Arunodhaya Siddartha Sujana Theja Vijay C and Abhilash Gowd

Case Report-Cancer Reports and Reviews (CRR)

December 27, 2016


A man patient with ipsilateral breast metastasis from pulmonary adenocarcinoma

Ayperi Ozturk Derya Yenibertiz Zafer Aktas Aydın Yılmaz Funda Demirag

Case Report-Cancer Reports and Reviews (CRR)

January 03, 2017


Symptoms based cancer diagnosis–An inconceivable strategy

Williams Fernandes Barra Taíssa Maíra Thomaz Araújo Danielle Queiroz Calcagno André Salim Khayat Sidney Emanuel Batista dos Santos Ney Pereira Carneiro dos Santos Carolina Baraúna Assumpção Aline Maria Pereira Cruz Geraldo Ishak Ândrea Kely Campos Ribeiro-dos-Santos Rommel Mario Rodriguez Burbano Gregory Joseph Riggins Paulo Pimentel de Assumpção

Review Article-Cancer Reports and Reviews (CRR)

January 20, 2017


Ratios of Zn/trace element contents in prostate gland as carcinoma’s markers

Vladimir Zaichick Sofia Zaichick

Research Article-Cancer Reports and Reviews (CRR)

January 23, 2017


A case study of rare lympho-epithelioma like esophageal carcinoma

Abhishek Mukherjee Jaydeep Nath Srimanti Sinha Tridip Chatterjee

Case Report-Cancer Reports and Reviews (CRR)

January 27, 2017


Submit Manuscript


CRR welcomes direct submissions from authors: Attach your word file with e-mail and send it to submissions@oatext.com alternatively to editor.crr@oatext.com

Publication Charges


Cancer Reports and Reviews is an Open Access journal and we do not charge the end user when accessing a manuscript or any article. This allows the scientific community to view, download, distribution of an article in any medium, provided that the original work is properly cited, under the term of "Creative Commons Attribution License". In line with other open access journals we provide a flat fee submission structure on the acceptance of a peer-reviewed article which covers in part the entirety of the publication pathway (the article processing charge). The process includes our maintenance, submission and peer review systems and international editing, publication and submission to global indexing and tracking organisations and archiving to allow instant access to the whole article and associated supplementary documents. We also have to ensure enough investment to secure a sustainable model which ethically, legally and financially stable.

The publication charges for Cancer Reports and Reviews are USD 1390/ GBP 1110.

Frequently Asked Questions (FAQs)

Why are your charges set at these levels?

All articles published in OA Text are open access. Open Access publishing implies that all readers, anywhere in the world, are allowed unrestricted to full text of articles, immediately on publication in OA Text Journals. The Article Publication Charges pay for the editorial and production costs of the journal, for hosting the website, publishing articles online, preparing HTML , PDF and XML versions of the articles and submitting the articles in electronic citation database like CrossRef.

Our financial goals are to:

  • Recover capitalization costs;
  • Produce sufficient revenue to allow for a sustainable and scalable publishing program, under continuous development;
  • Bend the publication-charge cost downward over time.

Who will pay the APC?

Corresponding author or Co-authors has to make the payment on acceptance of the article.

What type of articles are published for free?

Editorials, letters, comments, retractions, etc. will be published for free of charge. APC is applicable for the article types like Research, Review, Mini review, Case Reports, opinions etc.

When should I pay?

Corresponding author or the paying institutions should arrange for the payment once they are notified regarding acceptance of the article. APC is exempted for cases in which a wavier agreement has been made in-prior to submission.

*We request an immediate attention towards the payment as the articles will not be published unless the charges have been paid.

How do I pay?

Authors or institutions can make payments by two modes as per their convenience.

  1. Wire/Bank transfer
  2. Card payment

Note: No taxes are included in this charge, taxes will be applicable as per the policies of the country of the payee. Additional transaction charges may be levied on the author.

Can I be eligible for wavier on APC?

The waiver request will be considered on a case-by-case basis, and will be provided accordingly.

*The Waiver requests must be made during the submission process and will not be accepted after  processing of the manuscript.

Do I have to pay if my manuscript is rejected?

No, Article processing charges will not be applicable for articles rejected by the Editorial office.

Withdrawal Charges

Are reprints of my article included in the article processing charges (APCs)?

No, Article processing charges (APCs) do not include the charges for the reprints. Reprints facility is optional and should be order separately.

Special Issues


  • Breast Cancer

    Handling Editor:
    Adrian Pablo Hunis
    Board Certified in Medical Oncology
    Assistant Professor of Internal Medicine
    School of Medicine, University of Buenos Aires, Argentina
    Director, Specialist in Oncology, School of Medicine
    University of Buenos Aires (UBA), Argentina.
    Head Professor of Oncology, Maimonides University, Argentina

    Description/Purpose of the Special Issue and the current relevance:

    Few diseases have been targeted in the last 20 years of both development and worry as cancer patients, obviously to the extent that other disorders are cured or chronic, cancer in general and BREAST CANCER in particular, has been an issue where medical advances have been very important, reaching 90% of the patients in the early stages and achieving long survivors in patients with disseminated disease.

    New diiagnostic methods, new tumor markers, the contribution of molecular biology and the development of new and better therapies, have contributed to the fact that this disease, today is a model of cancer curable in the initial stages and a chronic disease and with long survival, In patients with metastasis.

    This special issue of Breast Cancer, from the Journal of Cancer Reports and Reviews, with the help of leading specialists, will try to bring to light some controversial aspects of this important chapter of human oncology, a real public health problem for the Western world.

    Topic includes but not limited to:

    Current state of molecular biology in breast cancer.
    Liquid biopsy and breast cancer.
    Genomic tests as predictors of treatment and prognosis.
    Advances in hormone therapy in breast cancer.
    Triple negative breast cancer, clinical and therapeutic update.
    Target therapies and immunotherapy, role in breast cancer.
    New radiotherapy treatments techniques.

    Tentative deadlines for submission: July, 15, 2017
    Tentative deadline for the issue release:  July, 30, 2017

    Submit manuscript to: editor.crr@oatext.com

>>>>>>>>>>>>>>> >>>>>>>>>>>>>>>>>>>>>>>>>